Vireo Growth Inc. (VREOD) Stock Price & Analysis
Vireo Growth Inc. (VREOD) fell 0.15% to USD 13.02 as of June 10, 2026 at 05:12 UTC, according to Nexqual real-time market data.
VREOD last closed at USD 13.04; the session ranged USD 12.85–13.8 on volume of 10,537 shares. Market capitalization is $641.57M, with a 52-week range of USD 9.69–24 (OQX). Source: Nexqual, June 10, 2026 at 05:12 UTC.
Key Statistics (as of June 10, 2026 at 05:12 UTC)
| Price | USD 13.02 |
|---|---|
| Change | ▼ 0.15% (down) |
| Previous Close | USD 13.04 |
| Open | USD 13.49 |
| Day Range | USD 12.85 – 13.8 |
| 52-Week Range | USD 9.69 – 24 |
| Volume | 10,537 shares |
| Market Cap | $641.57M |
| Exchange | OQX |
Technical Analysis (VREOD)
Nexqual's technical model rates VREOD "BUY" based on 5 bullish and 1 bearish signals across 123 daily candles, as of June 10, 2026 at 05:12 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 55.42 (neutral) |
| vs SMA50 | Above (USD 12.56) |
| MACD | 0.1 (positive) |
Analyst Ratings (VREOD)
Wall Street analysts rate VREOD "Strong Buy" based on 1 analysts, with a mean price target of USD 45 (range USD 45–45), per Nexqual as of June 10, 2026 at 05:12 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 45 |
| High Target | USD 45 |
| Low Target | USD 45 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (VREOD)
| Next Earnings Date | 2026-08-12 |
|---|---|
| EPS Estimate | USD 0.45 |
| Revenue Estimate | $164.55M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.06 vs est 0.15 ▼ miss |
| 2025-12-31 | USD -0.32 vs est 0.3 ▼ miss |
| 2025-09-30 | USD -0.2 vs est 0.3 ▼ miss |
| 2025-06-30 | USD -0.52 vs est -0.3 ▼ miss |
Source: Nexqual, June 10, 2026 at 05:12 UTC.
Financials & Fundamentals (VREOD)
| Total Revenue | $350.47M |
|---|---|
| Revenue Growth (YoY) | +333.50% |
| Gross Margin | +49.65% |
| Operating Margin | +16.67% |
| Profit Margin | -23.37% |
| ROE | -47.55% |
| Debt / Equity | 137.27 |
| Current Ratio | 1.2 |
| Total Cash | $123.40M |
| Total Debt | $403.70M |
| Free Cash Flow | $66.42M |
Source: Nexqual, June 10, 2026 at 05:12 UTC.
Financial Health Score (VREOD)
Nexqual rates Vireo Growth Inc.'s overall financial health "Solid" across five dimensions, as of June 10, 2026 at 05:12 UTC.
| Growth | Strong — Revenue +170% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 50%, operating 17% |
| Balance Sheet | Mixed — $123M cash vs $404M debt |
| Cash Flow | Strong — FCF $66M, 25% margin |
| Efficiency | Critical — ROE -48%, ROA 2.6% |
Ownership (VREOD)
| Insider Ownership | +33.19% |
|---|---|
| Institutional Ownership | +7.85% |
| Shares Outstanding | 48.50M |
| Float | 28.17M |
Source: Nexqual, June 10, 2026 at 05:12 UTC.
Leadership (VREOD)
Vireo Growth Inc. is led by John Michael Mazarakis (age 49), CEO & Co-Executive Chairman, per Nexqual as of June 10, 2026 at 05:12 UTC.
| CEO & Co-Executive Chairman | John Michael Mazarakis (age 49) |
|---|---|
| Founder & Co-Executive Chairman | Kyle E. Kingsley (age 49) |
| Chief Financial Officer | James Tyson Macdonald (age 50) |
| Chief Scientific Officer | Eric Greenbaum (age 46) |
| President & CEO of Vireo Health of Minnesota LLC | Amber H. Shimpa (age 46) |
From Vireo Growth Inc.'s Latest SEC 10-K Filing (filed 2026-03-17)
Key Strengths & Strategy (as disclosed to the SEC)
- Eaze is a vertically integrated cannabis retailer and delivery technology platform with operations in California, Florida, and Colorado. ​ The transaction is expected to represent Vireo's entry into the California and Florida cannabis markets.
- We are a vertically integrated cannabis company that operates from "seed-to-sale." We have three business lines: Cultivation Facilities We have rights to operate cultivation facilities in six states.
- Supply Chain We are vertically integrated in the markets in which we operate.
Partnerships
- Following the auction, Schwazze entered into an asset purchase agreement with a newly formed entity that as of the closing of the transaction is expected to ultimately be majority owned by the Company.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FFNTF | 4Front Ventures Corp. | USD 0 | ▲ 0% |
| CNTMF | FLUENT CORP | USD 0.03 | ▲ 2% |
| AYRWF | AYR WELLNESS INC. | USD 0.02 | ▼ 16.67% |
| VRNO | Verano Holdings Corp. | USD 1.24 | ▲ 5.98% |
| SHWZ | Medicine Man Technologies Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:12 UTC. This page is informational and not investment advice.